Tim Sims, co-founder and managing director of Pacific Equity Partners, argues that Australia’s strong fundamentals make it an attractive market for buyouts, while perceptions of an over-reliance on China are misplaced
Q: Your most recent deal, Spotless, was a take-private. How significant are lower public market valuations to deal-making at present? A: Traditionally public to private deals have not been that common...
Singapore sovereign wealth fund GIC Private saw its returns slow over the past year and warned the combination of high asset valuations, low interest rates and uncertain growth is likely to weigh on performance over at least the next decade.
India's Green House Ventures (GHV) Accelerator will partner with Japan and US-based early-stage investor World Innovation Labs (WiL) to launch a INR3.5 billion ($52 million) fund for investments in Indian start-ups.
KKR will exit India-based Gland Pharma as Shanghai Fosun Pharmaceutical acquires a majority stake in the business for up to $1.26 billion. KKR’s share of the proceeds will be $576.3 million, more than twice what it invested in Gland in 2014.
World Innovation Lab (WiL) has led a JPY1.1 billion ($10.6 million) investment in Japanese social media-oriented restaurant guide operator Retty.